Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
about
Lung microbiology and exacerbations in COPDDifferent durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseAntibiotics for exacerbations of chronic obstructive pulmonary diseaseProphylactic antibiotic therapy for chronic bronchitisAntibiotics for exacerbations of chronic obstructive pulmonary diseaseDifferent durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseAntibiotics for exacerbations of chronic obstructive pulmonary diseaseAntibiotics for acute exacerbations of chronic obstructive pulmonary diseaseAnticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary diseaseEffect of doxycycline in patients of moderate to severe chronic obstructive pulmonary disease with stable symptomsDouble-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitisAntibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitisIntrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [ISRCTN17802078]Action plans for COPD: strategies to manage exacerbations and improve outcomesThe optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infectionPositioning new pharmacotherapies for COPDSystemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patientsPneumonia in South-East Asia Region: public health perspectiveWhen should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelinesSymptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitisMoxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infectionsEpidemiology and management of common pulmonary diseases in older personsPneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Viral Etiology of Chronic Obstructive Pulmonary Disease Exacerbations during the A/H1N1pdm09 Pandemic and Postpandemic PeriodThe immunogenicity of the intradermal injection of seasonal trivalent influenza vaccine containing influenza A(H1N1)pdm09 in COPD patients soon after a pandemic.A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis.Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary diseaseWhere is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review.The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.A randomised controlled trial of the effect of automated interactive calling combined with a health risk forecast on frequency and severity of exacerbations of COPD assessed clinically and using EXACT PRO.Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT
P2860
Q22305860-387ABD7B-CB85-416B-BCA7-B41A01678A09Q24187361-32640599-E948-41D5-9C73-A0045B18C9E5Q24193908-D2D106F4-ED47-484B-98BE-8A94FB4AD637Q24202248-198E7243-2E52-45F0-943E-073DAF565997Q24202568-64E84020-AB4C-4726-BA62-A4A6201EE2CDQ24235050-84857EC1-CB85-44CC-9B40-11F226BB4009Q24235874-6D54EA28-4616-44CF-B605-BC615811A1B6Q24236699-F62EE670-9C4E-46A5-9051-26800FDECEF6Q24241135-70B8FF48-856F-4811-A14D-1A87887B0A60Q24246286-63EEF1D4-13A8-477E-AD08-4FC0D7C829F8Q24248596-C8F0C294-E52C-446A-9E3B-FF56FB0DD2EEQ24250271-504E74FD-FB82-4FC0-9335-C8F747320583Q24635347-288D7FAE-FBD3-4F67-B743-C8CD5ADF2AA6Q24670926-D29BC545-0B0F-4A3A-B5AF-327144B95AA5Q24803536-5847A966-F5AE-4987-A9AF-D987E2DA07CEQ24810625-00E0ED02-26CD-488F-A2B4-704CF6EBBA1AQ26744059-45A3FC28-007B-40AE-AFD5-151D64B413BBQ26752876-99A34218-F5C1-4D0A-A9A0-B66899719DE8Q26798659-874AE85B-71E4-48E1-AAEB-FD8E5E527FFCQ27010596-13DB2BF8-748A-4C97-857D-B0D27587BE67Q27027095-E7517A7E-5F27-458F-A024-FCD0CA24F82BQ28085429-E7AC817F-3A08-4402-842B-D80F0D815740Q28364409-5AEE7F54-DBF7-480F-AD8A-38CA79C12C28Q28373212-CCB11FB6-CB80-4810-A638-3B14211AF15AQ28397465-BB68C197-1D77-4ED8-B017-E05AC341349FQ30238816-066095B8-7586-4A56-B180-6B24B7626D68Q30375530-9C462703-66C6-4795-A81F-AA2C196AD9CEQ30387788-F4872A41-E72D-424D-BFCA-F80B3A4FAE14Q30998389-A5A3804C-110B-4ABC-9887-C1496649D014Q31158516-6605BE6A-E0D6-4233-BA47-A923BDC44C8DQ33182084-9FE962CC-196B-4628-B0DB-7846A65E9230Q33276665-774CC77B-B04A-47DC-BAB7-3FD90F35F34DQ33290142-FFB4ABA8-4B30-4A73-8305-132BA6634678Q33316582-A65053B0-81E5-4B8F-8DE5-062800A34C48Q33375199-E64A5B6D-18F6-443B-AE3A-F067B2298B6AQ33375205-4463EA3B-EFDC-45AC-9953-E52AF3346DA1Q33378956-3D8921BD-CDCB-4B26-A443-B883B8B3066FQ33438578-B8095351-E3FA-4E90-911E-7CEFAEBE77EDQ33491797-E0856701-BF12-4867-A6F4-59919F63D110Q33521100-00574095-6D79-4E39-9321-FB84F5E2EE0D
P2860
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@ast
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@en
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@nl
type
label
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@ast
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@en
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@nl
prefLabel
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@ast
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@en
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@nl
P2093
P1476
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
@en
P2093
Anthonisen NR
Harding GK
Hershfield ES
Manfreda J
P304
P356
10.7326/0003-4819-106-2-196
P407
P577
1987-02-01T00:00:00Z